MK-677 and Tesa/IPA Protocol Interaction

Monitor
Researched 90% confidence

MK-677 and Tesa/IPA Protocol have an interaction requiring monitoring for interaction with 90% confidence. Both affect GH release; combination may be excessive and affect glucose. Both compounds affect the pituitary, so monitoring these systems is recommended.

Compound Profiles

MK-677

Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue

Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..

Half-life: ~24 hours Typical dose: Start 12.5mg daily, increase to 25mg based on tolerance growth hormone, weight loss, sleep
ghrelin receptor blood pressure raisingcarcinogenic riskhepatotoxicinsulin disrupting
View full profile

Tesa/IPA Protocol

Tesamorelin + Ipamorelin GH Secretagogue Blend

The blend leverages two distinct GH-releasing pathways: Tesamorelin is a synthetic GHRH analog that directly stimulates growth hormone-releasing hormone receptors on pituitary somatotrophs, triggering GH synthesis and secretion in a pulsatile, physiological manner. Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist that amplifies GH pulses without significantly affecting cortisol or prolactin.

Typical dose: 200-500mcg total blend per injection growth hormone
ghrelin receptorghrh receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

Pituitary
low
Brain
low
GI Tract
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (MK-677, Tesa/IPA Protocol). Monitor accordingly.
2x 2 compounds affect insulin sensitivity (MK-677, Tesa/IPA Protocol). Monitor fasting glucose and HbA1c.
2x 2 compounds share the teratogenic safety flag (MK-677, Tesa/IPA Protocol). Monitor accordingly.

Frequently Asked Questions

Can I take MK-677 with Tesa/IPA Protocol?

Yes, but with caution. Both affect GH release; combination may be excessive and affect glucose. Regular monitoring is advised.

Is MK-677 and Tesa/IPA Protocol safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between MK-677 and Tesa/IPA Protocol?

Both affect GH release; combination may be excessive and affect glucose. This assessment has 90% confidence and is based on documented research data.

Check this pair in the full Interaction Checker Full comparison: MK-677 vs Tesa/IPA Protocol

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.